Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 23, 2006
Kidney cancer. Clinical practice guidelines in oncology
Robert J Motzer, Graeme B Bolger, Barry Boston, et al.
Cancer Immunology, Immunotherapy : CII
|
October 8, 2016
Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
Ajjai Alva, Gregory A Daniels, Michael K K Wong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 23, 2006
Testicular cancer. Clinical practice guidelines in oncology
Robert J Motzer, Graeme B Bolger, Barry Boston, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 10, 2009
Testicular cancer. Clinical practice guidelines
Robert J Motzer, Robert R Bahnson, Barry Boston, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 10, 2009
Kidney cancer. Clinical practice guidelines
Robert J Motzer, Michael A Carducci, Mayer Fishman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 27, 2009
NCCN clinical practice guidelines in oncology: testicular cancer
Robert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 27, 2009
NCCN clinical practice guidelines in oncology: kidney cancer
Robert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 10, 2017
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Clinical Genitourinary Cancer
|
December 6, 2016
Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM<sup>SM</sup>
Joseph I Clark, Michael K K Wong, Howard L Kaufman, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 23, 2006
Kidney cancer. Clinical practice guidelines in oncology
Robert J Motzer, Graeme B Bolger, Barry Boston, et al.
Cancer Immunology, Immunotherapy : CII
|
October 8, 2016
Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
Ajjai Alva, Gregory A Daniels, Michael K K Wong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 23, 2006
Testicular cancer. Clinical practice guidelines in oncology
Robert J Motzer, Graeme B Bolger, Barry Boston, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 10, 2009
Testicular cancer. Clinical practice guidelines
Robert J Motzer, Robert R Bahnson, Barry Boston, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 10, 2009
Kidney cancer. Clinical practice guidelines
Robert J Motzer, Michael A Carducci, Mayer Fishman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 27, 2009
NCCN clinical practice guidelines in oncology: testicular cancer
Robert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 27, 2009
NCCN clinical practice guidelines in oncology: kidney cancer
Robert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 10, 2017
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Clinical Genitourinary Cancer
|
December 6, 2016
Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM<sup>SM</sup>
Joseph I Clark, Michael K K Wong, Howard L Kaufman, et al.
Page
of 7